For research use only. Not for therapeutic Use.
Olodaterol Hydrochloride is a long-acting beta-2 adrenergic agonist (LABA) used in the management of chronic obstructive pulmonary disease (COPD). It works by stimulating beta-2 receptors in the smooth muscles of the airways, leading to bronchodilation and improved airflow. Olodaterol is designed for once-daily inhalation, providing sustained relief from bronchoconstriction and reducing COPD symptoms such as shortness of breath. Its selectivity for beta-2 receptors minimizes cardiovascular side effects, making it a valuable therapeutic option for improving lung function and enhancing the quality of life in patients with COPD.
Catalog Number | I008443 |
CAS Number | 869477-96-3 |
Synonyms | Olodaterol hydrochloride; Olodaterol HCl; BI-1744; BI 1744; BI1744; Olodaterol; Striverdi;(R)-6-hydroxy-8-(1-hydroxy-2-((1-(4-methoxyphenyl)-2-methylpropan-2-yl)amino)ethyl)-2H-benzo[b][1,4]oxazin-3(4H)-one hydrochloride |
Molecular Formula | C21H27ClN2O5 |
Purity | 98% |
Target | Neuronal Signaling |
Solubility | Soluble in DMSO |
Appearance | Off-white solid |
Storage | 0 - 4 °C for short term, or -20 °C for long term |
IUPAC Name | 6-hydroxy-8-[(1R)-1-hydroxy-2-[[1-(4-methoxyphenyl)-2-methylpropan-2-yl]amino]ethyl]-4H-1,4-benzoxazin-3-one;hydrochloride |
InChI | InChI=1S/C21H26N2O5.ClH/c1-21(2,10-13-4-6-15(27-3)7-5-13)22-11-18(25)16-8-14(24)9-17-20(16)28-12-19(26)23-17;/h4-9,18,22,24-25H,10-12H2,1-3H3,(H,23,26);1H/t18-;/m0./s1 |
InChIKey | KCEHVJZZIGJAAW-FERBBOLQSA-N |
SMILES | CC(C)(CC1=CC=C(C=C1)OC)NCC(C2=CC(=CC3=C2OCC(=O)N3)O)O.Cl |